Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis
- PMID: 28612347
- PMCID: PMC8030990
- DOI: 10.1111/jch.13042
Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis
Abstract
A meta-analysis was conducted to evaluate the association between duration of oral contraceptive use and risk of hypertension. Relevant studies published in English or Chinese were identified by a search of PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure to January 2017. Seventeen articles containing 24 studies with 270,284 participants were included in this meta-analysis. The pooled relative risk of hypertension for the highest vs lowest category of oral contraceptive duration was 1.47 (95% confidence interval, 1.25-1.73), and excluding three studies with a relative risk >3.0 yielded a pooled relative risk of 1.26 (95% confidence interval, 1.11-1.44). A linear dose-response relationship was found (Pnonlinearity =0.69) and the risk of hypertension increased by 13% (relative risk, 1.13; 95% confidence interval, 1.03-1.25) for every 5-year increment in oral contraceptive use. The duration of oral contraceptive use was positively associated with the risk of hypertension in this meta-analysis.
Keywords: hypertension; meta-analysis; oral contraceptive use.
©2017 Wiley Periodicals, Inc.
Conflict of interest statement
The authors report no conflicts of interest to disclose.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f085/8030990/66fd76c17139/JCH-19-1032-g003.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f085/8030990/5528052ff879/JCH-19-1032-g004.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f085/8030990/1356b0c1c997/JCH-19-1032-g001.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f085/8030990/10d9a727127a/JCH-19-1032-g002.gif)
Comment in
-
Response to: Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis: Methodological and statistical issues.J Clin Hypertens (Greenwich). 2018 Mar;20(3):614. doi: 10.1111/jch.13214. Epub 2018 Feb 15. J Clin Hypertens (Greenwich). 2018. PMID: 29447425 Free PMC article. No abstract available.
-
Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis, methodological and statistical issues.J Clin Hypertens (Greenwich). 2018 Mar;20(3):613. doi: 10.1111/jch.13208. Epub 2018 Feb 15. J Clin Hypertens (Greenwich). 2018. PMID: 29447432 Free PMC article. No abstract available.
Similar articles
-
Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.J Am Board Fam Pract. 1993 Mar-Apr;6(2):123-35. J Am Board Fam Pract. 1993. PMID: 8452064
-
Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis.Neurology. 1998 Aug;51(2):411-8. doi: 10.1212/wnl.51.2.411. Neurology. 1998. PMID: 9710012
-
A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy.Contraception. 1999 Sep;60(3):145-50. doi: 10.1016/s0010-7824(99)00079-7. Contraception. 1999. PMID: 10640157
-
Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1931-43. doi: 10.1158/1055-9965.EPI-13-0298. Epub 2013 Sep 6. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24014598 Review.
-
Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies.Hum Reprod. 2015 Sep;30(9):2234-40. doi: 10.1093/humrep/dev160. Epub 2015 Jul 3. Hum Reprod. 2015. PMID: 26141711 Review.
Cited by
-
Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys (Sapajus libidinosus).Int J Endocrinol. 2019 Mar 13;2019:2047803. doi: 10.1155/2019/2047803. eCollection 2019. Int J Endocrinol. 2019. PMID: 31001334 Free PMC article.
-
Oral Contraceptive Pills and Hypertension: A Review of Current Evidence and Recommendations.Hypertension. 2023 May;80(5):924-935. doi: 10.1161/HYPERTENSIONAHA.122.20018. Epub 2023 Feb 16. Hypertension. 2023. PMID: 37075131 Free PMC article. Review.
-
Effect of oral hormonal contraceptive pill use on the hemodynamic response to the cold pressor test.Am J Physiol Heart Circ Physiol. 2022 Jun 1;322(6):H1072-H1079. doi: 10.1152/ajpheart.00140.2022. Epub 2022 Apr 29. Am J Physiol Heart Circ Physiol. 2022. PMID: 35486478 Free PMC article. Clinical Trial.
-
Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.Arch Cardiol Mex. 2022;92(Supl 2):1-68. doi: 10.24875/ACM.22000071. Arch Cardiol Mex. 2022. PMID: 35666723 Free PMC article. English. No abstract available.
-
Response to: Association between duration of oral contraceptive use and risk of hypertension: A meta-analysis: Methodological and statistical issues.J Clin Hypertens (Greenwich). 2018 Mar;20(3):614. doi: 10.1111/jch.13214. Epub 2018 Feb 15. J Clin Hypertens (Greenwich). 2018. PMID: 29447425 Free PMC article. No abstract available.
References
-
- Benagiano G, Bastianelli C, Farris M. Contraception today. Ann N Y Acad Sci. 2006;1092:1‐32. - PubMed
-
- United Nations, Department of Economic and Social Affairs, Population Division . Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349). 2015. http://www.un.org/en/development/desa/population/publications/pdf/family.... Accessed December 11, 2016.
-
- Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205:S4‐S8. - PubMed
-
- Hatzipetros I, Gocze P, Farkas B. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta‐analysis. Obstet Gynecol. 2013;122:1114. - PubMed
-
- Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta‐analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16:1061‐1070. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical